Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 15th, there was short interest totaling 23,534 shares, an increase of 202.1% from the December 31st total of 7,789 shares. Currently, 0.9% of the company’s stock are short sold. Based on an average daily volume of 87,980 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily volume of 87,980 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.9% of the company’s stock are short sold.
Institutional Trading of Invesco Nasdaq Biotechnology ETF
Several institutional investors have recently bought and sold shares of the company. Osaic Holdings Inc. lifted its position in shares of Invesco Nasdaq Biotechnology ETF by 28.4% during the 2nd quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock valued at $101,000 after buying an additional 1,052 shares in the last quarter. MMA Asset Management LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF in the 3rd quarter worth $51,000. Advisory Services Network LLC purchased a new position in shares of Invesco Nasdaq Biotechnology ETF in the third quarter valued at about $52,000. Raymond James Financial Inc. bought a new position in shares of Invesco Nasdaq Biotechnology ETF in the second quarter worth about $149,000. Finally, Atria Investments Inc purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF during the second quarter worth about $211,000.
Invesco Nasdaq Biotechnology ETF Stock Performance
IBBQ stock opened at $29.10 on Friday. The firm has a market capitalization of $74.50 million, a price-to-earnings ratio of 17.03 and a beta of 0.67. The firm has a 50 day moving average price of $28.79 and a 200-day moving average price of $25.97. Invesco Nasdaq Biotechnology ETF has a 52-week low of $17.84 and a 52-week high of $30.13.
Invesco Nasdaq Biotechnology ETF Cuts Dividend
Invesco Nasdaq Biotechnology ETF Company Profile
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Recommended Stories
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
